Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 10 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,847 | $7.57 | $21,551.79 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 3 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,381,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,818 | $0.00 Strike: $7.57 | $0.00 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · derivative · entry 6 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,818 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 1,974 | $13.83 | $27,299.04 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 4 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,379,465 F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.82 to $13.835. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,818 | $7.57 | $21,332.26 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 3 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,381,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 197,153 | $0.00 Strike: $7.57 | $0.00 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · derivative · entry 5 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,847 Underlying: Common Stock · 197,153 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 136,193 | $13.58 | $1,849,868.66 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,378,546 F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 197,153 | $7.57 | $1,492,448.21 |
DisclosureSEC source: 0001193125-26-017056 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,514,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 197,182 | $0.00 Strike: $7.57 | $0.00 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · derivative · entry 5 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,818 Underlying: Common Stock · 197,182 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested and exercisable. The option is due to expire on February 19, 2026. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 136,193 | $13.59 | $1,850,794.77 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,378,621 F1 · kind: Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 02:46 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
Exercise / conversionCommon Stock | 197,182 | $7.57 | $1,492,667.74 |
DisclosureSEC source: 0001193125-26-017057 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,514,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:08 UTC |
MILNE GEORGE M JRDirector
|
GiftCommon Stock | 17,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-012921 · ownership.xml · nonDerivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,881 F1 · kind: Represents a bona fide gift for no consideration. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 7,715 | $11.09 | $85,596.38 |
DisclosureSEC source: 0001193125-26-007666 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,317,632 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.05 to $11.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 7,715 | $11.09 | $85,589.44 |
DisclosureSEC source: 0001193125-26-007664 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,317,586 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:05 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 3,326 | $11.11 | $36,953.86 |
DisclosureSEC source: 0001193125-26-007669 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,104 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.99 to $11.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 23, 2025 Filed Dec 24, 2025 01:48 UTC |
Firestone KarenDirector
|
PurchaseCommon Stock | 8,100 | $12.45 | $100,845.00 |
DisclosureSEC source: 0001193125-25-331289 · ownership.xml · nonDerivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,100 Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:39 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 6,580 | $14.35 | $94,418.39 |
DisclosureSEC source: 0001193125-25-306818 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,756 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.30 to $14.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 200 | $15.00 | $2,999.50 |
DisclosureSEC source: 0001193125-25-228340 · ownership.xml · nonDerivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,325,347 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.995 to $15.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 29,733 | $14.34 | $426,469.34 |
DisclosureSEC source: 0001193125-25-228340 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,325,547 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 200 | $15.01 | $3,002.00 |
DisclosureSEC source: 0001193125-25-228343 · ownership.xml · nonDerivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,325,301 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 29,775 | $14.37 | $427,950.12 |
DisclosureSEC source: 0001193125-25-228343 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,325,501 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.99 to $14.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 8,828 | $14.58 | $128,668.98 |
DisclosureSEC source: 0001193125-25-228342 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,141 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.355 to $15.075. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 10,558 | $14.65 | $154,650.42 |
DisclosureSEC source: 0001193125-25-228341 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,430 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.075. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 12,039 | $14.58 | $175,517.78 |
DisclosureSEC source: 0001193125-25-228339 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,336 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.35 to $15.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 13, 2025 Filed Aug 14, 2025 20:20 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 15,000 | $8.34 | $125,046.00 |
DisclosureSEC source: 0000950170-25-108912 · ownership.xml · nonDerivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,969 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.13 to $8.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:20 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 15,000 | $8.07 | $121,102.50 |
DisclosureSEC source: 0000950170-25-108912 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,969 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.82 to $8.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:06 UTC |
MILNE GEORGE M JRDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-083713 · ownership.xml · derivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 16:06 UTC |
Zeiher Bernhardt GDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-083709 · ownership.xml · derivative · entry 1 Zeiher Bernhardt G · CIK 0001971421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:12 UTC |
FONTEYNE PAUL R.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-083734 · ownership.xml · derivative · entry 1 FONTEYNE PAUL R. · CIK 0001727550 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:08 UTC |
Firestone KarenDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-083719 · ownership.xml · derivative · entry 1 Firestone Karen · CIK 0001969821 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:07 UTC |
Quimi DaphneDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0000950170-25-083717 · ownership.xml · derivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-06-04 F1 · derivative.exercise_date: The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:01 UTC |
Mazzariello GinaChief Legal Officer
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077677 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,969 F1 · kind: Represents a bona fide gift for no consideration. F1 · shares: Represents a bona fide gift for no consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:57 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 21,490 | $3.47 | $74,482.19 |
DisclosureSEC source: 0000950170-25-049513 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,355,280 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.435 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:52 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 21,490 | $3.46 | $74,454.25 |
DisclosureSEC source: 0000950170-25-049495 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,355,276 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:22 UTC |
FRATES JAMES MChief Financial Officer
|
SaleCommon Stock | 10,896 | $3.47 | $37,805.85 |
DisclosureSEC source: 0000950170-25-049581 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,988 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:14 UTC |
Bedrosian Camille LChief Medical Officer
|
SaleCommon Stock | 12,425 | $3.47 | $43,082.45 |
DisclosureSEC source: 0000950170-25-049567 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,375 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:12 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 9,192 | $3.48 | $31,954.15 |
DisclosureSEC source: 0000950170-25-049560 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,969 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.44 to $3.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 16:15 UTC |
Zeiher Bernhardt GDirector
|
PurchaseCommon Stock | 10,000 | $3.70 | $37,005.00 |
DisclosureSEC source: 0000950170-25-043849 · ownership.xml · nonDerivative · entry 1 Zeiher Bernhardt G · CIK 0001971421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:28 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 270,177 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000950170-25-036708 · ownership.xml · derivative · entry 2 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,177 Underlying: Common Stock · 270,177 shares Expires 2035-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:28 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
GrantCommon Stock | 180,118 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036708 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,376,770 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:30 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 270,177 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000950170-25-036711 · ownership.xml · derivative · entry 2 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,177 Underlying: Common Stock · 270,177 shares Expires 2035-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:30 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
GrantCommon Stock | 180,118 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036711 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,376,766 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:34 UTC |
Mazzariello GinaChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 95,777 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000950170-25-036717 · ownership.xml · derivative · entry 2 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,777 Underlying: Common Stock · 95,777 shares Expires 2035-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:34 UTC |
Mazzariello GinaChief Legal Officer
|
GrantCommon Stock | 63,851 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036717 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,161 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:28 UTC |
FRATES JAMES MChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 102,630 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000950170-25-036707 · ownership.xml · derivative · entry 4 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,630 Underlying: Common Stock · 102,630 shares Expires 2035-03-05 F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:28 UTC |
FRATES JAMES MChief Financial Officer
|
GrantCommon Stock | 68,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036707 · ownership.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,884 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:32 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 102,630 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0000950170-25-036712 · ownership.xml · derivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,630 Underlying: Common Stock · 102,630 shares Expires 2035-03-05 F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on March 1, 2026, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| March 06, 2025 Filed Mar 11, 2025 00:32 UTC |
Bedrosian Camille LChief Medical Officer
|
GrantCommon Stock | 68,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036712 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,800 F1 · shares: The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:32 UTC |
Cohen Joshua BDirector · Co-Chief Executive Officer
|
SaleCommon Stock | 4,595 | $3.17 | $14,549.15 |
DisclosureSEC source: 0000950170-25-033719 · ownership.xml · nonDerivative · entry 1 Cohen Joshua B · CIK 0001898644 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,196,652 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.09 to $3.195. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:35 UTC |
Klee Justin B.Director · Co-Chief Executive Officer
|
SaleCommon Stock | 4,595 | $3.15 | $14,483.44 |
DisclosureSEC source: 0000950170-25-033725 · ownership.xml · nonDerivative · entry 1 Klee Justin B. · CIK 0001898314 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,196,648 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.10 to $3.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:32 UTC |
Mazzariello GinaChief Legal Officer
|
SaleCommon Stock | 1,611 | $3.12 | $5,022.29 |
DisclosureSEC source: 0000950170-25-033717 · ownership.xml · nonDerivative · entry 1 Mazzariello Gina · CIK 0001913765 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,310 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F1 · shares: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.10 to $3.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.